[药物诱导的帕金森症:精神病学观点]
Shinto Kitada1, Takashi Tsuboi
1Department of Neuropsychiatry, Kyorin University School of Medicine.
药物诱导的帕金森症 (DIP) 是一种由阻断多巴胺受体的抗精神病药物等药物引起的疾病. 管理DIP包括停止或减少致病药物,特别是在精神分裂症患者中,以预防症状.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 药物诱导的帕金森症 (DIP) 是一种神经系统疾病.
- 它是由多巴胺受体阻断剂引起的,通常是抗精神病药物.
- DIP呈现出模仿特异性帕金森病的症状.
研究的目的:
- 为了定义药物诱导的帕金森症 (DIP).
- 概述DIP的临床表现和诊断标准.
- 推DIP的管理策略.
主要方法:
- 对药物治疗史的审查.
- 排除其他帕金森症的疾病.
- 对症状的临床观察.
主要成果:
- DIP的症状包括震,硬,勃拉迪基尼西亚和姿势不稳定.
- 诊断依赖于药物审查和差异诊断.
- 停止治疗或减少致病剂的剂量是有效的.
结论:
- 药物诱导的帕金森病是可逆的,当违规代理人撤回后.
- 建议精神分裂症患者切换到第二代抗精神病药物.
- 主动管理可以防止DIP的发展.
更多相关视频
06:45Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
10:41Implantation of Osmotic Pumps and Induction of Stress to Establish a Symptomatic, Pharmacological Mouse Model for DYT/PARK-ATP1A3 Dystonia
Published on: September 12, 2020
相关概念视频
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Psychosis and Antipsychotic Drugs: Overview
Psychosis: Goals of Pharmacotherapy
Antipsychotic Drugs: Therapeutic Uses and Side Effects
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
